Mood Disorders Information Center
No difference was observed in risk of overall cancer in patients with bipolar disorder who use lithium, compared with the general population.
For many off-label indications, the prescribed drug is often not supported by strong evidence for the respective indication.
Appropriate patient section for ketamine treatment should include diagnostic considerations and assessment of other medical, psychological, and social factors.
Differences in refusal rates for pharmacotherapy and psychotherapy were particularly evident for depressive disorders, panic disorder, and social anxiety disorder.
Reducing postpartum depression involves universal screening and appropriate referral and treatment by clinicians.
A better understanding of this complicated condition is key to helping patients reduce symptoms, maximize quality of life, and improve adaptive functioning skills.
Women with a good recovery after stroke and a moderate level of optimism had a 0.40‐fold reduction in the odds of developing new-onset poststroke depression.
Atypical antipsychotic adjunctive therapy and mood stabilizers may be a more effective treatment than mood stabilizer monotherapy.
Depression is common in patients receiving chronic hemodialysis but seems to be ineffectively treated.
Researchers measured vital status records to ascertain death from 16 site-specific malignancies.
Lithium has been the mainstay of treatment for decades, but several other classes of medication have recently been used with varying degrees of success.
Among all women, PPD risk increased with advanced age and gestational diabetes.
The declining rates for lithium use are linked to the burden of side effects and toxicity associated with the drug.
Men with diabetes, but not women, had excess mortality risk associated with depression and anxiety.
Some aspects of depression literacy were lower among patients with depression.